Development of gene therapy for pancreatic cancer

M. Sunamura, F. Motoi, M. Onuma, H. Abe, M. Matsuno

Research output: Contribution to journalReview article

Abstract

In order to develop the new therapeutic intervention for pancreatic cancer, we have examined the effect of gene therapy for this miserable pancreatic disease. The transfection of UPRT, a 5-FU converting enzyme, gene resulted in the significant change in sensitivity of pancreatic cancer cells against 5-FU. Anti-angiogenesis gene therapy has been also demonstrated to be a promising strategy for pancreatic cancer. It has been revealed that replication-competent adenoviruses are not only the strong weapon themselves but also useful carriers of genes possessing anti-tumor activities as virus vectors specific to tumors without normal p53 function nor intact Rb pathway. Whether these experimental results are universally true require the clinical trials in future.

Original languageEnglish
Pages (from-to)98-103
Number of pages6
JournalNippon rinsho. Japanese journal of clinical medicine
Volume59
Issue number1
Publication statusPublished - 2001 Jan

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Development of gene therapy for pancreatic cancer'. Together they form a unique fingerprint.

  • Cite this

    Sunamura, M., Motoi, F., Onuma, M., Abe, H., & Matsuno, M. (2001). Development of gene therapy for pancreatic cancer. Nippon rinsho. Japanese journal of clinical medicine, 59(1), 98-103.